范科米辛配方的制备时间和估计成本:差异是否重要?
Merton Lee1, Chad Worz2, Dana Gaal3
11 Peter Lamy Center on Drug Therapy and Aging, University of Maryland School of Pharmacy, Baltimore, Maryland.
The Senior care pharmacist
|April 30, 2024
概括
室温预混合的万科米辛为长期护理药房提供了显著的成本和时间节省. 这种配方是一种经济有效的解决方案,用于治疗感染,包括耐甲基黄金葡萄球菌.
科学领域:
- 制药科学 制药科学
- 传染性疾病 传染性疾病
- 医疗保健管理的管理
背景情况:
- 长期护理设施 (LTCFs) 越来越多地管理由甲素耐药黄金葡萄球菌 (MRSA) 引起的感染.
- 静脉注射的无菌万科米辛为LTCF药房带来了高昂的药品成本.
- 提供具有成本效益的药物供应对于管理LTCF中耐药生物的管理至关重要.
研究的目的:
- 为了比较长期护理药房中万科米辛制剂的药品成本.
- 评估外包,复合和室温预混合的万科米辛配方的制备时间.
- 确定在LTCF中使用万科米辛的成本效益高的策略.
主要方法:
- 对124个万科米辛类的回顾性观察性研究.
- 对三种万科米辛配方的药房总制备时间和药剂师劳动时间进行比较.
- 基于成分成本和国家中位数药剂师劳动力成本的成本计算.
主要成果:
- 室温预混合的万科米辛表现出最短的平均制备时间.
- 药房总费用对于预先混合的万科米辛 (809.36美元) 最低,其次是复合 (993.94美元) 和外包 (2220.34美元).
- 在完整的治疗过程中,预混合的平均准备时间为2小时8分钟,而复合的万科米辛则为5小时3分钟.
结论:
- 与熟练护理设施中的复合和外包选项相比,室温预混合的万科米辛提供了较短的准备时间.
- 对于管理复杂感染的LTCF来说,提供具有成本效益的药物是必不可少的.
- 在长期护理环境中,预混合的万科米辛为静脉注射提供了一个可行的,经济的替代方案.
更多相关视频
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
12.9K
11:28A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
29.0K
相关概念视频
01:09One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
245
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
245
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
197
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
197